Efficacy and safety of the human GLP-1 analog liraglutide in combination with metformin and TZD in patients with type 2 diabetes mellitus ( LEAD-4 Met + TZD )

@inproceedings{Zinman2009EfficacyAS,
  title={Efficacy and safety of the human GLP-1 analog liraglutide in combination with metformin and TZD in patients with type 2 diabetes mellitus ( LEAD-4 Met + TZD )},
  author={Bernard Zinman and Jane Gerich and John B Buse and Andrew W. Lewin and Sherwyn Schwartz and Philip Raskin and Paula M. Hale and Milan Zdravkovic and Lawrence Blonde},
  year={2009}
}
This is an uncopyedited electronic version of an article accepted for publication in Diabetes Care. The American Diabetes Association, publisher of Diabetes Care, is not responsible for any errors or omissions in this version of the manuscript or any version derived from it by third parties. The definitive publisherauthenticated version will be available in a future issue of Diabetes Care in print and online at http://care.diabetesjournals.org. Diabetes Care Publish Ahead of Print, published… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 51 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 22 references

Efficacy and safety comparison of liraglutide , glimepiride , and placebo , all in combination with metformin , in type 2 diabetes : the LEAD ( liraglutide effect and action in diabetes ) - 2 study

  • D Russell-Jones, A Vaag, +6 authors R Simo
  • Diabetes Care
  • 2009

Similar Papers

Loading similar papers…